Literature DB >> 2467162

Cell surface and intracellular expression of two Candida albicans antigens during in vitro and in vivo growth.

D L Brawner1, J E Cutler.   

Abstract

Intracellular and cell surface expression of two antigenic determinants of Candida albicans was studied by reacting ultrathin sections of the fungus with monoclonal antibodies and locating the sites of antibody-antigen reactions by use of colloidal gold-coupled secondary antibody and electron microscopic techniques. Comparisons were made between fungal cells allowed to develop in vitro and cells (in vivo) recovered from infected mice. Differences between in vitro antigen expression and expression in vivo were particularly noted during early germination events. Antigen expression in vivo appears to be concentrated in deeper cell wall layers and beneath the plasmalemma especially on germ tubes. Cells which develop in vivo and in vitro have antigen associated with an outer flocculent layer and on the innermost cell wall layer of mother cells and hyphae. A middle electron transparent cell wall layer is usually devoid of antigen. Comparison of antigen expression during in vivo growth in early (intraperitoneal) infection versus late disseminated (kidney) disease suggests that both of the antigens are expressed in greater quantity on the surface of germ tubes than on mother cells in kidney tissue as compared to intraperitoneally-grown cells. Results also suggest that at least one of the antigens, which is a substituted mannan, can be found on a lamello-tubular intracellular structure.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2467162     DOI: 10.1016/0882-4010(87)90123-9

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  14 in total

Review 1.  Cytological immunodetection of yeast glycoprotein secretion.

Authors:  J C Cailliez; D Poulain; D W Mackenzie; L Polonelli
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

Review 2.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

3.  Caveats in the investigation of form-specific molecules of Candida albicans.

Authors:  D L Brawner; J E Cutler; W L Beatty
Journal:  Infect Immun       Date:  1990-02       Impact factor: 3.441

4.  Immunochemical localization of nitrogenase in marine trichodesmium aggregates: relationship to n(2) fixation potential.

Authors:  H W Paerl; J C Priscu; D L Brawner
Journal:  Appl Environ Microbiol       Date:  1989-11       Impact factor: 4.792

Review 5.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

6.  Comparison between methods for serotyping of Candida albicans produces discrepancies in results.

Authors:  D L Brawner
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

7.  Partial biochemical characterization of cell surface hydrophobicity and hydrophilicity of Candida albicans.

Authors:  K C Hazen; J G Lay; B W Hazen; R C Fu; S Murthy
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

8.  Role of yeast cell growth temperature on Candida albicans virulence in mice.

Authors:  P P Antley; K C Hazen
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

9.  Oral Candida albicans isolates from nonhospitalized normal carriers, immunocompetent hospitalized patients, and immunocompromised patients with or without acquired immunodeficiency syndrome.

Authors:  D L Brawner; J E Cutler
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

10.  Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis.

Authors:  F De Bernardis; A Molinari; M Boccanera; A Stringaro; R Robert; J M Senet; G Arancia; A Cassone
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.